Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 in Lumbar Radiculopathy (Sciatica)
PHASE1CompletedINTERVENTIONAL
Enrollment
18
Participants
Timeline
Start Date
November 30, 2015
Primary Completion Date
July 31, 2017
Study Completion Date
July 31, 2017
Conditions
RadiculopathySciatica
Interventions
DRUG
VVZ-149
DRUG
Lidocaine
DRUG
Placebo
Trial Locations (1)
02115
Translational Pain Research, Brigham and Women's Hospital, Boston
All Listed Sponsors
lead
Brigham and Women's Hospital
OTHER
NCT02644421 - Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 in Lumbar Radiculopathy (Sciatica) | Biotech Hunter | Biotech Hunter